Paul Yang MD PhD
Cataract Related, Retinal Disease, Uveitis
Associate Professor, Ophthalmic Genetics & Ocular Immunology
Join to view full profile
545 SW Campus DrPortland, OR 97239
Phone+1 503-494-8311
Dr. Yang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health Science University HospitalFellowship, Ophthalmic Genetics and Inherited Retinal Degeneration, 2012 - 2013
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 2011 - 2012
University of Utah HealthFellowship, Surgical Retina and Vitreous, 2010 - 2011- University of Utah HealthResidency, Ophthalmology, 2007 - 2008
- University of Utah HealthInternship, Internal Medicine, 2006 - 2007
Certifications & Licensure
OR State Medical License 2012 - 2027
MA State Medical License 2011 - 2015
UT State Medical License 2007 - 2014
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- Split-spectrum amplitude decorrelation optoretinography for functional imaging of mouse photoreceptors.Alexander Matteson, Maya Helms, Luke Fraley, Alexander Hurt, Anna Andrews
Biomedical Optics Express. 2026-08-01 - Interim Results From a Multicenter Observational Safety Study of Patients Treated With Voretigene Neparvovec-rzyl in the United States.Aaron Nagiel, Stephen R Russell, Byron L Lam, Jason I Comander, Tomas S Aleman
Ophthalmology. 2026-07-22 - Novel variant c.428T>C in FZD4 gene in a pedigree affected by familial exudative vitreoretinopathy: clinical, functional, and structural characterization.Jia-Horung Hung, Quan Dong Nguyen, Chao-Kai Hsu, Yao-Tsung Chang, Woei-Jer Chuang
Ophthalmic Genetics. 2026-04-14
Press Mentions
SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt DiseaseMarch 14th, 2025- SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt DiseaseDecember 12th, 2024
- Gene Therapy Allows Teen to See Snowflakes for the First TimeApril 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
